Résultats de la recherche - Parent, Ephraim E
- Résultat(s) 1 - 15 résultats de 15
-
1
-
2
-
3
-
4
Neuro-Oncology Practice Clinical Debate: FDG PET to differentiate glioblastoma recurrence from treatment-related changes par Parent, Ephraim E, Johnson, Derek R, Gleason, Tyler, Villanueva-Meyer, Javier E
Publié 2021Texte -
5
-
6
Asymptomatic coronavirus disease 2019 mimicking metastatic breast cancer on positron emission tomography/computed tomography imaging par Pai, Tanmayi S., Rojas, Carlos, Wasserman, Martha C., Parent, Ephraim E., Cornell, Lauren, Chumsri, Saranya
Publié 2021Texte -
7
Letter regarding “Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients—a report of the PET/RANO group”: (18)F-fluciclovine and target volume delin... par Kotecha, Rupesh, Aboian, Mariam, Nabavizadeh, Seyed Ali, Parent, Ephraim E, Trifiletti, Daniel M, Chao, Samuel T
Publié 2021Texte -
8
-
9
Fluorine-18 Labeling and Biodistribution Studies on Peroxisome Proliferator-Activated Receptor-Gamma (PPARγ) Ligands: Potential Positron Emission Tomography (PET) Imaging Agents par Lee, Byung Chul, Dence, Carmen S., Zhou, Haibing, Parent, Ephraim E., Welch, Michael J., Katzenellenbogen, John A.
Publié 2009Texte -
10
The Continuum of Metastatic Prostate Cancer: Interpreting PSMA PET Findings in Recurrent Prostate Cancer par Kase, Adam M., Tan, Winston, Copland, John A., Cai, Hancheng, Parent, Ephraim E., Madan, Ravi A.
Publié 2022Texte -
11
[(18)F]-Fluciclovine PET discrimination of recurrent intracranial metastatic disease from radiation necrosis par Parent, Ephraim E., Patel, Dhruv, Nye, Jonathon A., Li, Zhuo, Olson, Jeffrey J., Schuster, David M., Goodman, Mark M.
Publié 2020Texte -
12
Neuropsychiatric Manifestations of Lymphoma-Associated Cerebral Glucose Hypometabolism Can Be Reversed by Intensive Glucose Supplementation par Kase, Adam M, Bullock, Catherine, Parrondo, Ricardo, Alhaj Moustafa, Muhamad, Iqbal, Madiha, Li, K David, Parent, Ephraim E, Tun, Han
Publié 2022Texte -
13
Exploratory study of (18)F-fluciclovine pet/ct for response assessment to docetaxel in patients with metastatic castration-resistant prostate cancer par Akintayo, Akinyemi A, Bilen, Mehmet A, Abiodun-Ojo, Olayinka A, Kucuk, Omer, Carthon, Bradley, Chen, Zengjia, Jani, Ashesh B, Parent, Ephraim E, Schuster, David M
Publié 2021Texte -
14
[(18)F]Fluciclovine PET discrimination between high- and low-grade gliomas par Parent, Ephraim E., Benayoun, Marc, Ibeanu, Ijeoma, Olson, Jeffrey J., Hadjipanayis, Constantinos G., Brat, Daniel J., Adhikarla, Vikram, Nye, Jonathon, Schuster, David M., Goodman, Mark M.
Publié 2018Texte -
15
(82)Rubidium chloride positron emission tomography discrimination of recurrent intracranial malignancy from radiation necrosis par PARENT, Ephraim E., SETHI, Ila, NYE, Jonathon, HOLDER, Chad, OLSON, Jeffrey J., SWITCHENKO, Jeffrey, TADE, Funmilayo, AKIN-AKINTAYO, Oladunni O., ABIODUN-OJO, Olayinka A., AKINTAYO, Akinyemi, SCHUSTER, David M.
Publié 2022Texte